medicalxpress.com
Researchers at the University of Pennsylvania have uncovered a critical link between the NF-κB signaling pathway and the maintenance of X chromosome inactivation in T cells, shedding new light on sex-based differences in immune responses. The study, published in Science Immunology, connects this key immune pathway to a fundamental process in female biology—X chromosome inactivation—which regulates gene expression and ensures cellular health.
The research team, led by Montserrat Anguera, focused on how X chromosome inactivation is maintained in T cells. This process is crucial for gene regulation in female mammals, as it silences one of the two X chromosomes in each cell. They discovered that the transcription factor NF-κB, which is essential for T cell development and immune responses, also plays a pivotal role in maintaining this inactivation when T cells are activated by an antigen.
This study marks the first time the NF-κB pathway has been directly linked to the regulation of X chromosome inactivation in T cells. The researchers used advanced techniques, such as allele-specific RNA sequencing and CUT&RUN, to map the epigenetic modifications on the X chromosome. They found that some X-linked genes escape transcriptional silencing in T cells, revealing a complex interaction between immune activation and gene regulation.
The team also collaborated with immunologists and experts on NF-κB signaling, leveraging human and mouse models to confirm their findings. They demonstrated that without proper NF-κB signaling, T cells cannot maintain X chromosome inactivation, potentially leading to immune dysregulation.
This research has significant implications for understanding why females are more prone to autoimmune diseases, which often involve dysregulated T cells. Females generally have a stronger immune response to pathogens, yet they are disproportionately affected by autoimmune disorders. The connection between NF-κB signaling and X chromosome inactivation may help explain these sex-based immune differences and provide new avenues for studying the genetic and epigenetic factors that contribute to autoimmune diseases.
Understanding how NF-κB regulates X inactivation could lead to better insights into diseases that disproportionately affect women, such as lupus and rheumatoid arthritis, where T cell dysfunction plays a major role. The findings also offer a potential roadmap for future research into targeted therapies that modulate NF-κB signaling to address these conditions.
The study not only advances our knowledge of immune system differences between sexes but also highlights the importance of X chromosome regulation in immune health. By elucidating the role of NF-κB in T cell function, this research opens the door to better understanding autoimmune disorders and could lead to the development of new treatments for diseases that disproportionately affect women. As autoimmune diseases are often characterized by abnormal T cell activity, targeting the NF-κB pathway may provide a promising therapeutic strategy.